You have no items in your cart.
BioNews Services covers more than 60 diseases, most of which are rare. Its global team of staff research scientists, reporters, and editors produce multi-platform content covering drug trials and approvals; research findings; issues affecting caregivers; treatment developments; FDA actions; social and cultural trends related to coping with rare diseases; and legislative issues that affect patient well-being.
In addition to the core editorial team, BNS content is augmented and richly humanized by a team of columnists. Each columnist either lives with a rare disease or cares for someone who does. They share thoughtful, personal insights into their daily lives and cover a full span of issues that affect the disease they’re living with.
And when major news breaks, as it has with the COVID-19 pandemic, BNS uses all its resources to provide multidimensional, in-depth coverage — news stories, analyses, columns, Q&As, in-depth interviews with leading experts, nuts-and-bolts resource information, and graphics.
In addition to extensive daily coverage, the service also produces quarterly special reports dedicated to covering high-profile topics in the news, ranging from major drug approvals affecting millions, advances or setbacks in research, public health emergencies, the spread of specific diseases, and much more.
A daily news digest, which is updated throughout the news cycle, helps front-line editors and content managers prioritize content quickly and efficiently. Further, all BioNews Services content is thoroughly fact-checked, edited, and proofread.
Finally, a portfolio of newsletters dedicated to specific diseases adds value and potential incremental advertising opportunities for service clients.